FDA Adverse Event Malfunction Summary report: N

ANIMAS INSULIN CARTRIDGE

MDR report key: 3052701 · Received April 11, 2013

Report

Report Number
2531779-2013-04066
Event Type
Malfunction
Date Received
April 11, 2013
Report Date
March 15, 2013
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K032257
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

FOLLOW-UP #1 DATE OF SUBMISSION 06/26/2013-DEVICE EVALUATION: THE CARTRIDGE WAS RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON 06/12/2013 WITH THE FOLLOWING FINDINGS:A VISUAL INSPECTION OF THE CARTRIDGE WAS PERFORMED. NO DAMAGE OR DEFECTS WERE NOTED. A LEAK TEST WAS PERFORMED WITH NO FAILURES OBSERVED. A RETAIN CARTRIDGE SAMPLE FROM THE SAME LOT WAS ALSO TESTED, WITH NO FAILURES OBSERVED. EACH CARTRIDGE LOT IS SUBJECTED TO A STATISTICAL SAMPLING PLAN AND MUST PASS TESTING FOR FORCE (OCCLUSION AND LOSS OF PRIME), CRACKS, AND FOREIGN MATERIAL PRIOR TO RELEASE FOR DISTRIBUTION.

Additional Manufacturer Narrative · 1

THE CARTRIDGE HAS NOT BEEN RETURNED TO ANIMAS. IF THE DEVICE IS RETURNED, AN EVALUATION SHALL BE COMPLETED AND A SUPPLEMENTAL REPORT WILL BE FILED. NO CONCLUSIONS CAN BE MADE AT THIS TIME.

Description of Event or Problem · 1

ON (B)(6) 2013, THE REPORTER CONTACTED ANIMAS, ALLEGING A SITE/SET/CART (CARTRIDGE LEAK) ISSUE. THE PATIENT STATED THAT SHE HAD EXPERIENCED HIGHER THAN NORMAL BLOOD GLUCOSE (BG) BUT DENIED SYMPTOMS AND DID NOT PROVIDE ANY BG VALUES. THE PATIENT NOTED THAT THE CARTRIDGE WAS RUNNING OUT OF INSULIN SOONER THAN IT SHOULD. THE CARTRIDGE COMPARTMENT IS REPORTEDLY DRY BUT SMELLS LIKE INSULIN. THIS COMPLAINT IS BEING REPORTED BECAUSE THE REPORTED ISSUE WAS NOT RESOLVED WITH TROUBLESHOOTING. THE REPORTED BG EXCURSIONS DO NOT MEET CRITERIA FOR A SERIOUS INJURY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
155509 ANIMAS INSULIN CARTRIDGE INSULIN PUMP CARTRIDGE LZG ANIMAS CORPORATION B201936

Patients

Seq Age Sex Outcome Treatment
1 53 YR